维普期刊资源整合服务平台（V6.5）

44篇 您的检索式：作者名="Enblad G"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas 显示文摘	Blystad A K Enblad G Kvalφy S	2001	Bone Marrow Transplant2001，27，7：	1
2	A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas显示文摘	Enblad G Hagberg H Erlanson M	2004	Blood2004，103，8：	1
3	PET-methionine of skull base neuromas and meningiomas显示文摘	Nyberg G Bergstrom M Enblad P	1997	Acta Otolaryngol1997，117，4：	1
4	High-dose therapy with autologous stem cell transplantation in patients with peripheral T-cell lymphomas显示文摘	Blystad AK Enblad G Kvaloyn S	2001	Bone Marrow2001，27，7：	1
5	High-dose therapy with autologous stem cell transplantation in patients with peripheral T- cell lymphomas显示文摘	Blystad AK Enblad G Kvaloyn S	2001	Bone Marrow2001，27，7：	1
6	Apilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas显示文摘	Enblad G Hagberg H Erlanson M	2004	Blood2004，103，8：	1
7	A pilot study of alemtuzumab( anti-CD52 monoclonal antibody)therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas 显示文摘	Enblad G Hagberg H Erlansen M	2004	Blood2004，103，8：	1
8	A pilot study of alemtuzumab(anti-CD52 monoclonal antibody)therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas显示文摘	Enblad G Hagberg H Erlanson M	2004	Blood2004，103，8：	1
9	A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas显示文摘	Enblad G Hagberg H Erlanson M	2004	Blood2004，103，8：	1
10	High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas 显示文摘	Blystad AK Enblad G Kvaloy S	2001	Bone Marrow Transplant2001，27，：	1
11	A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy lym- phomas for patients with relapsed or chemotherapy-refractory pe- ripheral T-cell显示文摘	ENBLAD G HAGBERG H ERLANSON M	2004	Blood2004，103，8：	1
12	High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas显示文摘	Blystad AK Enblad G Kvaloy S	2001	Bone Marrow Transplant2001，27，7：	1
13	Patients sufferingfrom both Hodgkin 1 s disease and non-Hodgkin * s lymphoma : aclinico-pathological and immuno-histochemical population-basedstudy of 32 patients显示文摘	Amini R M Enblad G Sundstrom C	1997	Int J Cancer1997，71，4：	1
14	A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral Tcell lymphomas 显示文摘	Enblad G Hagberg H Erlanson M	2004	Blood2004，103，8：	1
15	PET-methionine of skull base neuromas and meningiomas显示文摘	Nyberg G Bergstrom M Enblad P	1997	Acta Otolaryngol (Stockh)1997，117，：	1
16	Telomerase activity in Hodgkin's disease显示文摘	Norrback K F Enblad G Erlanson M	1998	Blood1998，92，2：	1
17	A pilot study of alemtu- zumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lym- phomas显示文摘	Enblad G Hagberg H Erlanson M	2004	Blood2004，103，8：	1
18	Inflammatory cells and immune microenvironment in malignant lymphoma 显示文摘	de Jong D Enblad G	2008	J Intern Med2008，264，6：	1
19	Inflammatory cells and immune microen- vironment in malignant lymphoma 显示文摘	De Jong D Enblad G	2008	J Intern Med2008，264，6：	1
20	A pilot study of alemtuzumab(anti 52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas显示文摘	Enblad G Hagberg H Erlanson M	2004	Blood2004，103，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示